Research at The Neuro

Patients at The Neuro benefit from clinical trials

Gordon Kumson’s brain cancer treatment was first ever in Canada

More

Scientist Brenda Milner, born in 1918, pioneered memory research at The Neuro

More

Dr. Edward Fon identifies Open Science as a motor for accelerating drug discoveries

He  is the Scientific Director of The Neuro and a clinician-scientist 

More

Dr. Lan Xiong's main research objective is to discover the genes that influence the development of disorders such as schizophrenia and autism

More

Yasser Iturria-Medina applies mathematical models to the study of neurological disorders

More

Maryse Thomas studies auditory neuroplasticity, which is how the sounds we hear shape our brains throughout our lives

More

Over the last several years, The Neuro has focused more attention on research into rare diseases

More

Research at The Neuro

On this page: Info about our research | Info for researchers

Each year The Neuro trains300+ graduate students and postdoctoral fellows from around the world

Researchers at The Neuro are world leaders in cellular and molecular neuroscience, brain imaging, cognitive neuroscience and the study and treatment of neurological diseases and disorders.

At The Neuro, bench meets bedside.

As a teaching and research institute of McGill, The Neuro is at the centre of McGill’s strategic plan in research and training in the neurosciences. The Neuro is the cornerstone of the University’s largest graduate program, the Integrated Program in Neurosciences and a key site for McGill's clinical training programs in Neurology and Neurosurgery.

Information about researchers, research programs and facilities

Researcher conducting test at The Neuro. 

 

Research Groups

Neuro faculty members lead international research teams that generate fundamental information that spans the full spectrum of neuroscience from cell and molecular biology to brain imaging and cognitive neuroscience. 

Brain Tumour

Cognitive Neuroscience

Epilepsy

Neural Circuits

Neurodegenerative Diseases

Neurodevelopmental Disorders

Neuroimaging and Neuroinformatics

Neuroimmunological Diseases

Rare Neurological Diseases

All researchers and clinicians at The Neuro

Interdisciplinary Programs

The Neuro’s multidisciplinary teams, including an additional 220 academic staff, generate fundamental information that spans the full spectrum of neuroscience from cell and molecular biology to brain imaging and cognitive neuroscience.

The programs listed below, offered in partnership with The Neuro, provide scientists and researchers with opportunities to engage in novel cross-disciplinary research, integrating neuroscience with principles of engineering and the physical sciences.

The NeuroEngineering Program and the Rio Tinto Laboratory of NeuroEngineering at The Neuro

The NeuroEngineering Program is a merger of physical and biological sciences. Together, physicists, chemists, materials scientists, computer engineers and neuroscientists tackle the challenges of creating interfaces between neurons and artificial substrates to restore the function of a damaged nervous system.
website

Canadian Neurophotonics Platform

The Neurophotonics Centre is a unique, state-of-the-art national facility for advanced Biophotonics approaches dedicated toward the understanding of the brain, the development of diagnostics for brain disorders and phototherapy. The centre brings together a team of researchers, scientists and staff who develop and use the most innovative methods integrating neuroscience and physics.
website

Translational Research

One of the unique aspects of The Neuro is the integration of fundamental biological research with applied research in human physiology and mechanisms of human disease.

Clinical Research Unit

The Neuro’s Clinical Research Unit (CRU) evaluates the efficacy of new drugs and treatment regimens. Many patients come to The Neuro because they want to have access to the newest medications and diagnostic procedures. 
website

GBA-Quebec Study Group (G-QUEST) – Parkinson’s Disease

Parkinson’s disease (PD) is the second most common neurodegenerative disorder, with a prevalence of 1-2% of the population over the age of 60. As the world’s population ages, the number of PD patients in 2050 is projected to be 25-50 million. Since PD is a long, slowly progressive disease, the financial, social, psychological and health implications are huge.
read more

 

 

Information for researchers at The Neuro

Conceptual illustration of neuron cells with glowing link knots in abstract dark space

 

Lab Safety Information and Document Centre

Research Ethics Board

Multi-Centre Mechanism

As of February 1, 2015, a study to be conducted at two or more institutions within the Quebec public health and social services network will be subject to:

  • One ethics review for all sites conducted by the REB of Record (or CER évaluateur)
  • Site specific assessment (or examen de convenance) at each site
  • Research authorization by the mandated person (personne mandatée) at each site

With these changes, the following review mechanisms will be replaced as of February 1, 2015:

  • The McGill IRB review process;
  • The 2008 Multi-Centre Study Mechanism.

Me Marie Hirtle was appointed as mandated person for the MUHC (MNH) by the Board of Directors.

More information on the 2014 Mechanism is available at MSSS Direction de l`éthique et de la qualité.

MUHC Research privileges

As per rule 3 of the “Plan d’action ministériel en éthique de la recherche et en intégrité scientifique”, research privileges are needed to conduct research in a healthcare institution in Québec. Therefore, MUHC research privileges are needed to conduct research involving MNH patients and/or MNH resources.

The steps to obtained research privileges at the MUHC are as follows:

  1. Go to researchportal.muhc.mcgill.ca
  2. Request a login to the MUHC RI Portal. An assistant should be able to do this for the PI. The login information will be emailed to the PI, so they will have to check their email.
  3. Log in.
  4. Navigate to the research privilege application. You click the “Research” tab, then “Fast Track,” then “Privileges.”
  5. Fill out the application. The system will generate a certificate for research privileges.
  6. Keep a copy of the research privileges for your files.

* The two contact people at the MUHC are Cindy Young, who approves new accounts, and Cindy Intini, who manages the MUHC RI portal.

Cindy Young
cindy.young [at] muhc.mcgill.ca

Cindy Intini
Cindy.Intini [at] MUHC.MCGILL.CA
Tel:514-934-1934 ext.71457

How to submit and manage projects with Nagano platform

The Neurosciences Panel of the MUHC REB is now using the Nagano platform for the management and review of research projects.

As of March 7, 2016, Neuro researchers must use the Nagano platform for all their ethics submissions (new and ongoing projects) made to the Neurosciences Panel of the MUHC REB. No paper copies or e-mail submissions will be accepted.

Please visit this web page often, as information will be updated regularly.

To access the platform: https://nagano.muhc.mcgill.ca/login

How does it work?

  • If you are a principal investigator with ongoing protocols, you may access Nagano with your “@mcgill.ca” or your “@mail.mcgill.ca” email address and your McGill password.
  • Otherwise, please send an email to reb.neuro [at] mcgill.ca with your McGill short username, “@mcgill.ca” or “@mail.mcgill.ca” e-mail address and your full name. (Please consider that it may take up to 48 hours (2 working days) before your account is created.)
  • Procedure to create new projects with Nagano (French only) click here
  • Information on how to access and submit forms for annual renewal, amendments, etc. during the conduct of a research project (French only) click here.
  • How to manage the Nagano users for a project (French only) click here.
  • Nagano user guide (French only) click here
  • Training video: English version only

Contact information

In case of difficulty or for any query regarding Nagano, please contact:

Linda Zegarelli
MUHC Research Ethics Board
Neurology and Psychiatry Panel Coordinator
Montreal Neurological Institute and Hospital
T.514.398.1046 /F.514.398.1375
E-mail: reb.neuro [at] mcgill.ca

OR

James Ellasus
Centre for Applied Ethics,
MUHC
Tel: 514-934-1934, ext. 34323
E-mail: info.nagano [at] muhc.mcgill.ca

FAQ about the Nagano platform

Q: Are there submission deadlines?

A: No, there are no submission deadlines, please submit your projects when they are ready.

Q: Is the connection to Nagano secured?

A: Yes the connection is secured.

Q: Once the submission is completed, what should I do if I want to make changes?

A: Contact Linda Zegarelli or James Ellasus to ensure that your project is not already in treatment. They will give you the necessary information to make your changes.

Q: Is it possible for different people to insert documents simultaneously?

A: Yes. Everyone who has an access to a project can access the form to complete the different sections and add documents.

Q: When I log into Nagano, which projects will I access?

A: You will have access to all your active and shared projects.

Q: How can I give someone access to my project?

A: Only the principal Nagano user for a project can give someone access to this project. Only someone with an MUHC/Neuro Nagano account can be added/removed as a « user » on a project. Procedure (French only) click here.

Q: Where can I find the link to Nagano?

A: You will find the Nagano link higher on this page or on the MUHC Centre for Applied Ethics website.

Q: Who do I need to contact if I have a problem with Nagano?

A: Linda Zegarelli (514-398-1046 or reb.neuro [at] mcgill.ca)

James Ellasus (514-934-1934, ext. 34323 or info.nagano [at] muhc.mcgill.ca).

Q: What is the recommended browser to use Nagano?

A: Google Chrome is the browser of choice for using Nagano. Microsoft Internet Explorer (version 8 or above) was tested and guarantees the compatibility of the basic functions of Nagano. Safari has been tested sporadically and is functional.

Q: Will I receive an email when I will need to fill a renewal form?

A: Yes, an email is sent to the email address linked to your Nagano account unless you have changed the default parameters in the “Activity Follow-up” tab of your profile.

Q: Can I change the email address linked to my Nagano account?

A: Yes. By accessing your profile, you can add a second email address in the "preferred email" tab. This address will be used first.

Q: If I did not have time to complete the entire form, do I lose the filled out fields?

A: No. Each section of the form is saved individually. Just click the button "save and continue" after each question. You can fill out the same form over several days / times of the day.

Q: When creating a project, I can say that my project is a multicenter project only if …

A: My project involves two centers or more in Quebec, including my institution.

Q: Is the English version of Nagano available?

A: Nagano is currently being translated. Parts of Nagano are already translated but the platform is not currently functional in English. Please use the French version until further notice.

Q: I receive many e-mail notifications from Nagano. How can I select the type of notification I want to receive?

A: In your profile, click on the “Activity Follow-up” tab and select the Nagano and e-mail notifications you wish to receive (French only) Click here

Q: How can I verify the status of my project?

A: On your project page, click on the blue “status” button.

Q: What is the “Mise à jour du projet” form?

A: This form was created to populate the Nagano database with the information that we could not migrate from your project’s paper file. This form gets created automatically the 1st time you update a project that was migrated to Nagano. You will have the choice to upload the last approved version of your project’s documents with this form or at the time of your project’s 1st Continuing Review in Nagano.

Q: Why must I upload the last approved version of all my project’s documents with the “Mise à jour du projet” form or at the time of it’s 1st Continuing Review in Nagano?

A: We could not migrate the documents from your project’s paper file to the Nagano database. We therefore ask you to upload them in Nagano to ensure your Nagano project file is complete going forward. You will have the choice to upload the last approved version of your project’s documents with the “Mise à jour du projet” form or at the time of your project’s 1st Continuing Review in Nagano. Please keep in mind that this step must be completed only once and is only applicable for projects that were migrated to Nagano.

For any further information, please contact:

Linda Zegarelli
MUHC Research Ethics Board
Neurology and Psychiatry Panel Coordinator
Montreal Neurological Institute and Hospital
3801, University Street,
Room: 686
Montreal, Quebec,
H3A 2B4

 

Tel: 514-398-1046
Fax: 514-398-1375
E-mail: reb.neuro [at] mcgill.ca

Useful links

MUHC Centre for Applied Ethics website

Guide for writing research protocols: click here

For more information on changes and updates to policies and procedures of the MUHC REBs, please go to the MUHC Centre for Applied Ethics website

Neuro Media Services

Neuro Media Services

  • meeting poster design and printing
  • illustrative & photographic services
  • wide range of multimedia services, including video recording and editing, video conferencing,
  • Desktop Publishing & Web Design and more

NeuroInformation Technology Services

NeuroInformation Technology Services

  • provides direction and support for the use of computing-related products and services which enhance the teaching, research and administrative functions of The Neuro

 

Tags: 

The Neuro logo McGill logoMcGill University Health Centre logoKillam logo

The Neuro is a McGill research and teaching institute; delivering the highest quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.